The ROE as of September 2024 (TTM) for Scholar Rock Holding Corporation (SRRK) is -114.96%

According to Scholar Rock Holding Corporation’s latest financial reports and current stock price. The company's current ROE is -114.96%. This represents a change of 281.18% compared to the average of -30.16% of the last 4 quarters.

Scholar Rock Holding Corporation (SRRK) Historical ROE (quarterly & annually)

How has SRRK ROE performed in the past?

The mean historical ROE of Scholar Rock Holding Corporation over the last ten years is -27.87%. The current -114.96% ROE has changed 312.43% with respect to the historical average. Over the past ten years (40 quarters), SRRK's ROE was at its highest in in the December 2017 quarter at 15.80%. The ROE was at its lowest in in the June 2024 quarter at -43.79%.

Scholar Rock Holding Corporation (SRRK) ROE by Quarter and Year

Discovering the peaks and valleys of Scholar Rock Holding Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Scholar Rock Holding Corporation (SRRK) Average ROE

How has SRRK ROE performed in the past?

The current ROE of Scholar Rock Holding Corporation (SRRK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Scholar Rock Holding Corporation (SRRK) ROE vs. Peers

How is SRRK’s ROE compared to its peers?

Scholar Rock Holding Corporation’s ROE is greater than TCR2 Therapeutics Inc. (-89.51%), greater than Revolution Medicines, Inc. (-34.57%), greater than Black Diamond Therapeutics, Inc. (-69.08%), greater than Atreca, Inc. (-195.22%), greater than Passage Bio, Inc. (-70.73%), greater than Monte Rosa Therapeutics, Inc. (-70.40%), greater than Design Therapeutics, Inc. (-18.48%), greater than Werewolf Therapeutics, Inc. (-48.25%), greater than Ikena Oncology, Inc. (-42.81%), greater than Stoke Therapeutics, Inc. (-57.89%), greater than IDEAYA Biosciences, Inc. (-20.53%), greater than AnaptysBio, Inc. (-255.67%), greater than MeiraGTx Holdings plc (-86.28%), greater than Keros Therapeutics, Inc. (-44.73%), greater than Homology Medicines, Inc. (-100.91%), greater than Avidity Biosciences, Inc. (-32.89%), greater than IGM Biosciences, Inc. (-119.02%), greater than Cerevel Therapeutics Holdings, Inc. (-98.94%), greater than Cullinan Oncology, Inc. (-28.37%), greater than Mineralys Therapeutics, Inc. (-42.61%), greater than Relay Therapeutics, Inc. (-43.66%), greater than Pliant Therapeutics, Inc. (-41.05%), greater than Arvinas, Inc. (-55.59%),

Build a custom stock screener for Scholar Rock Holding Corporation (SRRK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Scholar Rock Holding Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Scholar Rock Holding Corporation (SRRK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Scholar Rock Holding Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.